Navigation Links
North Shore-LIJ's Feinstein Institute Hosts Academic Commencement and Convocation
Date:5/28/2013

Manhasset, NY (PRWEB) May 28, 2013

The 2013 Commencement Exercises for the Elmezzi Graduate School of Molecular Medicine and the Academic Convocation for the Hofstra North Shore-LIJ School of Medicine were held May 23 at The Feinstein Institute for Medical Research. Each year during this event, the Elmezzi Graduate School awards an honorary degree to an outstanding physician who has advanced biomedical research and improved medical treatment for patients. This year, Frederick W. Alt, PhD, from Harvard Medical School and Boston Children's Hospital, was recognized for his work in cancer and immunology.

During the commencement exercises for the Elmezzi Graduate School, students who have completed their dissertation studies are granted the degree of Doctor of Philosophy, Molecular Medicine. The Elmezzi Graduate School of Molecular Medicine is a PhD program for physicians who wish to pursue careers in biomedical education. During their training, Elmezzi students conduct research in Feinstein Institute laboratories to advance biomedical knowledge and to pursue new therapeutic approaches and diagnostic tools. This year, three graduate students received their degrees:

  •     Eitan Giat, MD, for his work in lupus. His thesis is entitled “The Inhibition of the Interferon Signature by the Dweus Peptide through Inactivation of HMGB1.”
  •     Ben Lu, MD, for his work in inflammation. His thesis is entitled “The Regulation of HMGB1 Release.”
  •     Sergio I. Valdes-Ferrer, MD, for his work in sepsis. His thesis is entitled “HMGB1 is a Key Mediator of Sustained Inflammation in Sepsis Survivors.”

The academic convocation for the Hofstra North Shore-LIJ School of Medicine acknowledged all current professorships and presented the new School of Medicine professors. Those who received honorary professorships include:

  •     Veronica M. Catanese, MD, MBA, vice dean/dean for Academic Affairs of Hofstra North Shore-LIJ School of Medicine, received the Dr. Leo A. Guthart Endowed Chair.
  •     Betty Diamond, MD, head of the Center for Autoimmune and Musculoskeletal Diseases at the Feinstein Institute, received the Maureen and Ralph Nappi Professor of Autoimmune Diseases at The Feinstein Institute for Medical Research.
  •     Samuel Packer, MD, professor of Ophthalmology at the Hofstra North Shore-LIJ School of Medicine, received the Florence and Robert Kaufman Professor of Medical Ethics.
  •     Charles Schleien, MD, professor of Pediatrics at the Hofstra North Shore-LIJ School of Medicine, received the Philip Lanzkowsky, MD Professor of Pediatrics.

In addition, Frederick W. Alt, PhD, was presented with an honorary degree: Candidate for Degree of Doctor of Science honoris causa. Dr. Alt is the Charles A. Janeway Professor of Pediatrics in the Department of Pediatrics at Harvard Medical School, a professor in the Department of Genetics at Harvard Medical School, and an investigator in the Howard Hughes Medical Institute at Boston Children's Hospital. Throughout his career, Dr. Alt has studied cellular mechanisms that generate and suppress genome instability associated with cancer and the mechanisms employed by the immune system to generate diverse antibody repertoires. His current work continues to focus on areas where the fields of cancer biology and immunology intersect.

About The Elmezzi Graduate School of Molecular Medicine

Located in Manhasset, NY, The Elmezzi Graduate School of Molecular Medicine is part of the North Shore-LIJ Health System and in partnership with The Feinstein Institute for Medical Research. The Elmezzi Graduate School of Molecular Medicine was established in 1994 and is a PhD program for physicians who wish to pursue careers in biomedical research. The program is an individually tailored program with a strong emphasis on translational research. For more information, visit http://www.ElmezziGraduateSchool.org.

About The Feinstein Institute for Medical Research

Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in many areas including Parkinson's disease, Alzheimer’s disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North Shore-LIJ Health System, ranks in the top 5th percentile of all National Institutes of Health grants awarded to research centers. For more information, visit http://www.FeinsteinInstitute.org.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10775139.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New online portal, app provide information on tsunami zones in the Northwest
2. A North American first at the Montreal Heart Institute
3. Symtrex Inc. Signs Up with ImmuneSecurity to Launch LogInspect to the North American Market
4. Northwestern launches comprehensive program for patients with bicuspid aortic valve disease
5. Northwestern Medicine hosts the National Marfan Foundations Annual Conference
6. Northwestern researchers investigate treatment for tumor cells in spinal fluid
7. North Texas Cities to Start West Nile Spraying Thursday
8. Northeasterns Barnett Institute announces formation of leading analytics company, BioAnalytix, LLC
9. Power Slowly Returns to Much of Northeast After Sandy
10. Kessler awarded $2 million federal grant for Northern NJ Traumatic Brain Injury System
11. Heart Health Worst in the South, Best in Northeast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... ... ... crisis. Her son James, eight, was out of control. Prone to extreme mood shifts and ... him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife on ... say he was going to kill them. If we were driving on the freeway, ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital ... area economy by obtaining investment capital for emerging technology companies. SCP has ... have already resulted in more than a million dollars of capital investment for ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  In a startling report released today, ... their residents by lacking a comprehensive, proven plan to eliminate prescription ... definitive ranking of how states are tackling the worst drug crisis ... four states – Kentucky , New ... Vermont . Of the 28 failing states, three – ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology: